Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Endovia Health Sciences, Inc. (EDVA)

Endovia Health Sciences raises investor ownership cap in equity line from 4.99% to 9.99%

Neutral Impact 3 of 5 financing Written later

Endovia Health Sciences amended its equity line of credit agreement with C/M Capital Master Fund, LP, raising the beneficial ownership limit on the investor from 4.99% to 9.99%, effective immediately. The change allows the investor to hold a larger stake under the facility, which could increase potential share issuance and dilution for existing shareholders, though the filing does not state any amount of shares or proceeds.

Key points

  • Beneficial ownership limit raised from 4.99% to 9.99% under the Purchase Agreement, effective October 15, 2026
  • Parties also waived notice requirements and other provisions inconsistent with the Letter Agreement
  • Original Securities Purchase Agreement dated September 19, 2025 was filed as Exhibit 10.3 to a September 25, 2025 8-K
  • Investor's resales are covered by Form S-1 (File No. 333-298112), declared effective August 24, 2026

The filing

CompanyEndovia Health Sciences, Inc. (EDVA)
Form8-K, current report
Filed with the SECOct 15, 2026, 4:10 PM ET
Accession number0001731122-26-001347

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.